Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Nicholas Ingraham and Jeffrey Chipman.
Nicholas Ingraham
Connection Strength
0.615
Jeffrey Chipman
  1. Understanding the renin-angiotensin-aldosterone-SARS-CoV axis: a comprehensive review. Eur Respir J. 2020 07; 56(1).
    View in: PubMed
    Score: 0.223
  2. Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2. Crit Care. 2020 04 28; 24(1):182.
    View in: PubMed
    Score: 0.220
  3. A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19. EClinicalMedicine. 2021 Jul; 37:100957.
    View in: PubMed
    Score: 0.059
  4. Characterizing COVID-19 clinical phenotypes and associated comorbidities and complication profiles. PLoS One. 2021; 16(3):e0248956.
    View in: PubMed
    Score: 0.059
  5. Antihypertensive drugs and risk of COVID-19? Lancet Respir Med. 2020 05; 8(5):e30-e31.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.